124 related articles for article (PubMed ID: 36598364)
1. YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Jin J; Chen F; He W; Zhao L; Lin B; Zheng D; Chen L; He H; He Q
Cancer Res; 2023 Mar; 83(5):786-803. PubMed ID: 36598364
[TBL] [Abstract][Full Text] [Related]
2. Decreased SATB2 expression is associated with metastasis and poor prognosis in human clear cell renal cell carcinoma.
Guo C; Xiong D; Yao X; Gu W; Zhang H; Yang B; Peng B; Liu M; Zheng J
Int J Clin Exp Pathol; 2015; 8(4):3710-8. PubMed ID: 26097552
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP.
Liu S; Yang Y; Wang W; Pan X
J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Keap1 contributes to poor prognosis and Axitinib resistance of renal cell carcinoma via upregulation of Nrf2 expression.
Huang H; Wu Y; Fu W; Wang X; Zhou L; Xu X; Huang F; Wu Y
Int J Mol Med; 2019 May; 43(5):2044-2054. PubMed ID: 30896860
[TBL] [Abstract][Full Text] [Related]
5. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
Li Y; Liu YH; Hu YY; Chen L; Li JM
World J Gastroenterol; 2016 Oct; 22(38):8528-8539. PubMed ID: 27784965
[TBL] [Abstract][Full Text] [Related]
6. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
[TBL] [Abstract][Full Text] [Related]
7. Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP.
Lv M; Li S; Luo C; Zhang X; Shen Y; Sui YX; Wang F; Wang X; Yang J; Liu P; Yang J
Oncotarget; 2016 Mar; 7(11):12393-403. PubMed ID: 26848622
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of SATB2 Associates with Tumor Growth and Predicts Worse Outcome in Patients with Clear Cell Renal Cell Carcinoma.
Sliwinska-Jewsiewicka A; Kowalczyk AE; Krazinski BE; Godlewski J; Kwiatkowski P; Kiewisz J; Grzegrzolka J; Dziegiel P; Kmiec Z
Anticancer Res; 2018 Feb; 38(2):839-846. PubMed ID: 29374710
[TBL] [Abstract][Full Text] [Related]
9. SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells.
Tao W; Zhang A; Zhai K; Huang Z; Huang H; Zhou W; Huang Q; Fang X; Prager BC; Wang X; Wu Q; Sloan AE; Ahluwalia MS; Lathia JD; Yu JS; Rich JN; Bao S
EMBO Mol Med; 2020 Dec; 12(12):e12291. PubMed ID: 33124191
[TBL] [Abstract][Full Text] [Related]
10. Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.
Song S; Nguyen V; Schrank T; Mulvaney K; Walter V; Wei D; Orvis T; Desai N; Zhang J; Hayes DN; Zheng Y; Major MB; Weissman BE
Mol Cancer Res; 2020 Dec; 18(12):1777-1788. PubMed ID: 32855269
[TBL] [Abstract][Full Text] [Related]
11. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
[TBL] [Abstract][Full Text] [Related]
12. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
13. SATB2 overexpression promotes oral squamous cell carcinoma progression by up-regulating NOX4.
Gao J; Meng Y; Ge X; Hou CX; Zhu QH; Wang YZ; Sun LF; Wang CX; Li HQ; Zhang T; Ye JH
Cell Signal; 2021 Jun; 82():109968. PubMed ID: 33675939
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of SATB2: a novel independent prognostic marker of worse outcome in laryngeal carcinoma patients.
Liu TR; Xu LH; Yang AK; Zhong Q; Song M; Li MZ; Hu LJ; Chen FJ; Hu ZD; Han P; Zeng MS
PLoS One; 2012; 7(7):e40704. PubMed ID: 22815795
[TBL] [Abstract][Full Text] [Related]
15. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans.
Yu W; Roy SK; Ma Y; LaVeist TA; Shankar S; Srivastava RK
J Cell Mol Med; 2019 Dec; 23(12):7999-8009. PubMed ID: 31602781
[TBL] [Abstract][Full Text] [Related]
16. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2.
Ge X; Gao J; Sun QW; Wang CX; Deng W; Mao GY; Li HQ; Guo SS; Cheng J; Wu YN; Ye JH
J Cell Physiol; 2020 May; 235(5):4856-4864. PubMed ID: 31663131
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
[TBL] [Abstract][Full Text] [Related]
19. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.
Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A
Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242
[TBL] [Abstract][Full Text] [Related]
20. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]